课题基金 / 基金详情

VASCULAR RESEARCH TRAINING

VASCULAR RESEARCH TRAINING
血管研究培训
批准号:
6901872
负责人:
JEFFREY R. BENDER
金额:
$37.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2006-06-30

项目摘要

项目成果

JEFFREY R. BENDER的其他基金

相似基金

相关文献

中文摘要
翻译
(改编自申请人摘要)本培训计划的目标是 为医生提供实验室研究培训(M.D. M.D.博士)和 博士血管生物学博士后科学家,为职业生涯做准备 作为血管生物学相关学科的独立研究者。 学员的选择将基于对血管的承诺 生物学和强大的先前研究经验或潜力相同。 未来 医学科学家是这项培训计划的主要对象。 三年 要求为三名博士后研究员提供支助, 项目的第一年。 耶鲁大学分子心脏生物学中心 医学的Boyer分子医学中心和心血管 内科医学部,将是中央基础, 节目 然而,由于血管生物学渗透到广泛的领域, 临床医学和基础生物学研究,该计划将与 多个临床和基础科学部门。 对此的见证是 主要参与教师的部门隶属关系,其中包括 内科学(肺和心血管医学),病理学, 遗传学、免疫生物学、生理学和生物学。 部门间 耶鲁大学的血管研究团体将通过这次培训 计划并提供以下领域的研究机会:1)分子 白细胞-内皮细胞相互作用的决定因素和后果:2) 血管凋亡和抗凋亡信号的调节; 3) 凝血蛋白对血管细胞活化和损伤的作用; 4) 抗内皮同种异体反应中的细胞因子和膜受体; 5)体内 同种异体和异种移植模型中的血管基因递送; 6)调节 血管细胞中响应缺氧的细胞保护基因; 7)使用 遗传学方法来评估G蛋白介导的信号转导, 真核生物; 8)血管细胞整联蛋白生物学,既控制粘附, 参与的分子后果; 9)使用化学遗传方法, 研究抗血管生成化合物; 10)鉴定和绘制基因, 通过分子生物学途径, 遗传学技术; 11)神经体液和细胞的微循环分析 控制血管舒缩的偶联机制;和12)调节 正常生理和疾病中的内皮一氧化氮释放。 这一广泛 血管研究的基础强调了血管的强度和广度 耶鲁医学院的生物学,并强调了许多研究 博士后培训生的机会。 一个强大的教育课程将 提供,包括专门为博士后研究员开设的教学课程, 研究生院内的课程,以及基于程序和 多部门研究研讨会和期刊俱乐部。 进展将是 通过若干机制进行监测,包括受训人员个人的进展情况 委员会。
英文摘要
(Adapted from applicant's abstract) The goal of this training program is to provide laboratory research training for physician (M.D. and M.D./Ph.D.) and Ph.D. postdoctoral scientists in vascular biology, in preparation for careers as independent investigators in blood vessel biology-related disciplines. Selection of trainees will be based on a demonstrated commitment to vascular biology and strong prior research experience or potential of same. Future physician-scientists are major targets for this training program. Three years of support, per trainee, are requested, for three postdoctoral fellows in the first year of the program. The Molecular Cardiobiology Unit at Yale School of Medicine's Boyer Center for Molecular Medicine, and the Cardiovascular Medicine Division of Internal Medicine, will be the central foundations for the Program. However, because vascular biology pervades wide areas of clinical medicine and basic biologic research, the program will interact with multiple clinical and basic science departments. Testimonies to that are the departmental affiliations of the primary participating faculty, which include Internal Medicine (Pulmonary and Cardiovascular Medicine), Pathology, Genetics, Immunobiology, Physiology and Biology. The interdepartmental vascular research community at Yale will coalesce through this training program and provide research opportunities in the following area: 1) molecular determinants and consequences of leukocyte-endothelial cell interactions: 2) regulation of vascular apoptotic and anti-apoptotic signals; 3) effects of coagulation proteins on vascular cell activation and injury; 4) the role of cytokines and membrane receptors in anti-endothelial alloresponses; 5) in vivo vascular gene delivery in allo- and xenograft models; 6) regulation of cytoprotective genes in vascular cells in response to hypoxia; 7) use of genetic methods to evaluate G protein-mediated signal transduction in eukaryotes; 8) vascular cell integrin biology, both control of adhesion and molecular consequences of engagement; 9) use of chemical genetic approaches to study anti-angiogenic compounds; 10) identification and mapping of genes that contribute to the development of vascular disease in humans, through molecular genetic techniques; 11) microcirculatory analysis of neurohumoral and cell coupling mechanisms which control vasomotion; and 12) regulation of endothelial nitric oxide release in normal physiology and disease. This broad base of vascular research underscores the strength and breadth of vascular biology at the Yale School of Medicine, and highlights the numerous research opportunities for postdoctoral trainees. A strong educational curriculum will be provided, including didactic courses specifically for postdoctoral fellows, courses within the graduate school, as well as both program-based and multi departmental research seminars and journal clubs. Progress will be monitored through several mechanisms, including individual trainee progress committees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IL-17A mRNA-targeted oligonucleotide therapeutics in Idiopathic Pulmonary Fibrosis (IPF)
Immune cell skewing with RNA target site oligonucleotides to promote vascular smooth muscle cell homeostasis
  • 批准号:
    10593490
  • 项目类别:
  • 资助金额:
    $25.13万
  • 财政年份:
    2022
  • 负责人:
    JEFFREY R. BENDER
  • 依托单位:
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis
  • 批准号:
    10287633
  • 项目类别:
  • 资助金额:
    $22.11万
  • 财政年份:
    2021
  • 负责人:
    JEFFREY R. BENDER
  • 依托单位:
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis
  • 批准号:
    10426347
  • 项目类别:
  • 资助金额:
    $18.24万
  • 财政年份:
    2021
  • 负责人:
    JEFFREY R. BENDER
  • 依托单位:
国内基金
海外基金
Research on Quantum Field Theory without a Lagrangian Description
  • 批准号:
    24ZR1403900
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    SATOSHI NAWATA
  • 依托单位:
Cell Research
Cell Research
Cell Research (细胞研究)